Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Lung cancer screening: history, current perspectives, and future directions.

Sharma D, Newman TG, Aronow WS.

Arch Med Sci. 2015 Oct 12;11(5):1033-43. doi: 10.5114/aoms.2015.54859.

2.

Screening for lung cancer with low-dose computed tomography: a review of current status.

Marshall HM, Bowman RV, Yang IA, Fong KM, Berg CD.

J Thorac Dis. 2013 Oct;5 Suppl 5:S524-39. doi: 10.3978/j.issn.2072-1439.2013.09.06. Review.

3.

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC.

Lung Cancer. 2013 Nov;82(2):238-44. doi: 10.1016/j.lungcan.2013.07.017. Epub 2013 Aug 7.

4.

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB.

Chest. 2013 May;143(5 Suppl):e78S-e92S. doi: 10.1378/chest.12-2350. Review.

5.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

6.

Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea: a Canadian population-based study.

Walker SL, Saltman DL, Colucci R, Martin L; Canadian Lung Association Advisory Committee.

Can Respir J. 2010 Nov-Dec;17(6):287-94.

7.

Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer.

Dominioni L, Poli A, Mantovani W, Rotolo N, Imperatori A.

Eur J Epidemiol. 2011 Jan;26(1):79-80. doi: 10.1007/s10654-010-9519-4. Epub 2010 Oct 23.

8.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Hocking WG, Hu P, Oken MM, Winslow SD, Kvale PA, Prorok PC, Ragard LR, Commins J, Lynch DA, Andriole GL, Buys SS, Fouad MN, Fuhrman CR, Isaacs C, Yokochi LA, Riley TL, Pinsky PF, Gohagan JK, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2010 May 19;102(10):722-31. doi: 10.1093/jnci/djq126. Epub 2010 May 4.

9.

Lung cancer: current diagnosis and treatment.

Hammerschmidt S, Wirtz H.

Dtsch Arztebl Int. 2009 Dec;106(49):809-18; quiz 819-20. doi: 10.3238/arztebl.2009.0809. Epub 2009 Dec 4. Review.

10.

Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Apelberg BJ, Onicescu G, Avila-Tang E, Samet JM.

Am J Public Health. 2010 Feb;100(2):341-8. doi: 10.2105/AJPH.2008.147223. Epub 2009 Dec 17.

11.

A pause for thought on lung cancer screening.

Stanbrook MB, Flegel K.

CMAJ. 2009 Apr 14;180(8):793. doi: 10.1503/cmaj.090521. No abstract available.

12.

Survival from lung cancer in England and Wales up to 2001.

Zee YK, Eisen T.

Br J Cancer. 2008 Sep 23;99 Suppl 1:S43-6. doi: 10.1038/sj.bjc.6604584. No abstract available.

13.

Cancer screening in renal transplant recipients: what is the evidence?

Wong G, Chapman JR, Craig JC.

Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2:S87-S100. doi: 10.2215/CJN.03320807. Review.

14.

Computed tomography screening for lung cancer.

McMahon PM, Christiani DC.

BMJ. 2007 Feb 10;334(7588):271. No abstract available.

15.

Screening chest radiography: results from a Greek cross-sectional survey.

Kamposioras K, Casazza G, Mauri D, Lakiotis V, Cortinovis I, Xilomenos A, Peponi C, Golfinopoulos V, Milousis A, Kakaridis D, Zacharias G, Karathanasi I, Ferentinos G, Proiskos A.

BMC Public Health. 2006 Apr 29;6:113.

Supplemental Content

Support Center